BioChemPartner.com - Your Best Biochemistry Lab Partner

Home
Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials
About Us
Service

Custom Synthesis

Technical Support

Bulk Quantity Discounts
Contact Us
中文

New Products

SU-5408

Cat. NO.：BCP29247

CAS NO.：15966-93-5
Bromfenac Sodium Sesquihydrate

Cat. NO.：BCP29284

CAS NO.：120638-55-3
Spongouridine

Cat. NO.：BCP29295

CAS NO.：3083-77-0
Pentoxifylline

Cat. NO.：BCP29306

CAS NO.：6493-05-6
Bisoctrizole

Cat. NO.：BCP29317

CAS NO.：103597-45-1
Cynarin

Cat. NO.：BCP29379

CAS NO.：30964-13-7
2-Fluoro-6-iodo-pyrazine

Cat. NO.：BCP29567

CAS NO.：1286744-13-5
1-Methylcyclopropene

Cat. NO.：BCP29566

CAS NO.：3100-04-7
GDC-0575

Cat. NO.：BCP20675

CAS NO.：1196541-47-5
BI-1347

Cat. NO.：BCP29562

CAS NO.：2163056-91-3

Custom Synthesis

Contact us for technical support. BioChemPartner is able to provide a comprehensive QC data package which maybe includes newest COA, HPLC,LC-MS,NMR etc.
Technical Support

Contact us for technical support. BioChemPartner is able to provide a comprehensive QC data package which maybe includes newest COA, HPLC,LC-MS,NMR etc.
Bulk Quantity Discounts

Competitive discounts on bulk quantities. BioChemPartner could offer attractive discounts on bulk quantities as either individual item or multiple products.

Publications Citing Use ofBioChemPartnerProducts

Cell.2018 Aug.,174(4):Pages 856-869.e17
European J Pharm Sci.2018 Nov;124:273-287
Acta Pharmacol Sin. 2018
Int J Pharm.2018 Jun 10;544(1):100-111
Nat Prod Res. 2018 Apr.
AAPS PharmSciTech.2018 Jul.;19(5):2133–2143
Nanomedicine.2018 Aug.;14(6):1765-1776
Asian J Pharm Sci.2018 Jun.;1
Kidney Blood Press Res.2018;43:820-835
Mater Sci Eng.2018 Dec;93:36-48
United States Patent Application 20180200258
J Mater Chem B.2018 Aug.
Int J Pharm.2018 Oct 25;550(1-2):89-99.
Oncol Lett. 2018 Sep.;16(3):3439-3446
World J Gastroenterol. 2016 Apr 21; 22(15).
Virol J. 2017; 14: 2.
Virol J. 2017; 14: 55.
United States Patent Application 20140323346
United States Patent Application 20150306112
United States Patent Application 20160324978
Ultrasound Med Biol. 2017 Nov;43(11):2651-2669.
Tumour Biol. 2014 Oct;35(10):9759-67.
Tumour Biol. 2016 May;37(5):5951–5961
Tumour Biol. 2016 Jun;37(6):7305-14.
Toxicology. 2014 Apr 6;318:22-31.
Toxicol Appl Pharmacol. 2016 Nov 15;311:88-98.
Sci Rep. 2016; 6: 25806.
Sci Rep. 2017; 7: 10393.
Sci Rep. 2017; 7: 12953.
Sci Rep. 2017; 7: 5519.
RSC Adv. 2018, 8, 444-453
Redox Biol. 2017 Apr; 11: 524–534.
Pulm Pharmacol Ther. 2016 Jun;38:1-9.
Protein Cell. 2017 Apr; 8(4): 273–283.
Powder Diffraction.2015 Sep;30(3):298-299
PLoS One. 2012; 7(12): e52483.
PLoS One. 2014; 9(10): e109198.
PLoS One. 2014; 9(2): e89080.
PLoS One. 2015; 10(7): e0134051.
PLoS One. 2016; 11(3): e0150567.
PLoS One. 2017; 12(6): e0178168.
PLoS One. 2017; 12(7): e0182019.
PLoS One. 2017; 12(9): e0185088.
Oncotarget. 2016 Mar 1; 7(9): 9876–9889.
Oncotarget. 2016 May 3; 7(18): 25224–25240.
Oncotarget. 2016 Jun 14; 7(24): 36767–36782.
Oncotarget. 2016 Oct 11; 7(41): 67071–67086.
Oncol Rep. 2014 Aug;32(2):716-22.
Oncol Rep. 2016 Jun;35(6):3460-70.
Oncol Lett. 2016 Jul; 12(1): 387–392.
Nat Med. 2013 Nov; 19(11): 1518–1523.
Nanoscale. 2014 Mar 21;6(6):3231-42.
Nanoscale. 2015;7(20):9298-310.
Nanomedicine (Lond). 2017 Apr;12(8):911-925.
Mol Pharmacol. 2012 Nov;82(5):958-71.
Mol Oncol. 2017 Aug; 11(8): 1065–1077.
Mol Oncol. 2017 Oct; 11(10): 1430–1447.
Mol Med Rep. 2017 Jul; 16(1): 192–200.
Mol Cancer Ther. 2012 Jul;11(7):1557-64.
Mol Cancer Ther. 2014 Jun;13(6):1589-98.
Mol Cancer Ther. 2017 Oct;16(10):2130-2143.
Mol Biosyst. 2012 Oct 30;8(12):3185-96.
Microb Pathog. 2017 Jan;102:36-41.
Med Sci Monit. 2017; 23: 801–808.
mBio. 2014 Jul-Aug; 5(4): e01275-14.
Lett Drug Des Discov.2014 Jul;11(6):731-735(5).
Lett Drug Des Discov.2014 Nov;11(9):1090-1095(6).
J Proteome Res. 2013 Jul 5;12(7):3104-16.
J Pharmacol Toxicol Methods. 2017 Mar - Apr.
J Pharm Pharmacol. 2015 Oct;67(10):1393-405.
J Pharm Biomed Anal. 2016 Sep 10; 129: 473–481.
J Med Chem. 2012 Jun 28;55(12):5784-96.
J Exp Bot.2015 Sep; 66(19): 5713–5725
J Ethnopharmacol. 2015 Mar 13;162:369-76.
J Control Release. 2016 Nov 10;241:68-80.
J Control Release. 2017 Sep 10;261:126-137
J Biomed Nanotechnol.2016 Jul,12(7): 1463-1477.
J Asian Nat Prod Res. 2017 Oct 15:1-10.
Int J Pharm. 2015 Nov 10;495(1):265-75.
Int J Oncol. 2017 Oct 16.
Int J Neuropsychopharmacol. 2015 Jun; pyv006.
Int J Nanomedicine. 2015; 10: 6185–6198.
Int J Nanomedicine. 2016; 11: 2329–2343.
Int J Mol Med. 2016 Sep;38(3):969-75.
Int J Cancer.2012 December 1;131(11):2487–2498
Int J Antimicrob Agents. 2015 Oct;46(4):381-8.
Int Immunopharmacol. 2014 Feb;18(2):213-6.
Free Radic Res. 2016 Oct;50(10):1106-1115.
Expert Opin Ther Targets. 2012 Apr;16:S61-70.
Expert Opin Pharmacother.2012;13(17):2533-2543
Exp Ther Med. 2013 Feb; 5(2): 433–437.
Exp Ther Med. 2017 Oct; 14(4): 3105–3111.
Epigenetics Chromatin. 2017; 10: 24.
Environ Toxicol Pharmacol. 2017 Jan;49:81-88.
Environ Sci Technol. 2013 Feb 5;47(3):1373-80.
EBioMedicine. 2016 Jan; 3: 54–66.
Drug Metab Dispos. 2015 Nov;43(11):1751-9.
Drug Des Devel Ther. 2015; 9: 4613–4620.
Drug Des Devel Ther. 2017; 11: 3481–3489.
Curr Mol Med. 2015;15(5):478-86.
Curr Eye Res. 2017 Apr;42(4):534-541.
Cryst. Growth Des. 2016;16 (11):6537–6546
Cryst. Growth Des.2017;17 (11):5994–6005
Colloids Surf B Biointerfaces. 2016 May;141:83-92.
Clin Cancer Res. 2011 Apr 15;17(8):2140-8.
Clin Cancer Res. 2012 Nov 15;18(22):6219-26.
Clin Cancer Res. 2014 Nov 15; 20(22): 5686–5696.
Clin Cancer Res. 2015 Jan 1; 21(1): 166–174.
Cell Signal.2012 Sep;24(9):1781-1789
Cell Signal. 2012 Sep;24(9):1803-9.
Cancer Res. 2010 Dec 15;70(24):10402-10.
Cancer Biol Ther. 2014 Jun 1; 15(6): 721–734.
Br J Pharmacol. 2016 Aug; 173(15): 2352–2368.
Br J Cancer. 2011 Sep 6;105(6):807–813.
Br J Cancer. 2012 Feb 14;106(4):763–767.
Biosci Trends. 2013 Oct;7(5):237-44.
Bioorg Med Chem. 2014 Jul 15;22(14):3739-48.
Bioorg Med Chem. 2015 Oct 1;23(19):6477-85.
Bioorg Med Chem. 2015 Dec 15;23(24):7765-76.
BioMed Res Int.2017
Biomed Pharmacother.2014 Apr;68(3):335-341
Biomed Pharmacother. 2015 Dec;76:65-72.
Biomaterials. 2014 Jan;35(1):550-66.
Biomaterials. 2016 Sep; 101: 108–120.
Biomater Sci. 2015 Jul 1; 3(7): 1114–1123.
Biomacromolecules. 2017 Jun 12;18(6).
Biomacromolecules. 2017 Jun 12;18(6).
Biomacromolecules. 2018 Jan 19
Bioconjugate Chem.2018 Jan 17
Biochim Biophys Acta. 2018 Jan;1864(1):226-237.
Biochem Pharmacol. 2014 Sep 15;91(2):217-30.
Biochem Biophys Res Commun.2018 Jan;495(1).
Biochem Biophys Res Commun.2014 Apr;447(1).
Biochem Biophys Res Commun.2013 Jun;435(3).
Biochem Biophys Res Commun. 2013 May;434(4).
Biochem Biophys Res Commun. 2013 Jun;435(3).
Autophagy. 2015 Feb; 11(2): 355–372.
Atherosclerosis. 2016 Apr;247:48-57.
Antimicrob Agents Chemother. 2017 May;61(6).
Antimicrob Agents Chemother. 2017 Aug;61(9).
Antimicrob Agents Chemother. 2014 Aug; 58(8).
Acta Pharm Sinica B.2017 Sep.
Acta Biomater. 2017 Nov;63:150-162.
Acta Biomater. 2017 Apr 15;53:399-413.
ACS Biomater. Sci. Eng.2017; 3 (5):843–853
Oncogene. 2011 Sep 29;30(39):4097-106.
Nat Commun. 2015;6:7227.
Nat Commun. 2015; 6: 7360.
Cell Death Dis. 2017 May 4;8(5):e2766.

Products are for research use only. Not for human use. We do not sell to patients.

Terms&Conditions | Privacy Policy

Custom Synthesis

Technical Support

Bulk Quantity Discounts

Publications Citing Use ofBioChemPartnerProducts

About BioChemPartner

Customer Support

Ordering

Contact BioChemPartner